Bio-Rad Laboratories, Inc. (BIO) vs Teladoc Health, Inc. (TDOC)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnBIO vs TDOC

growth of $100 · dividends reinvested · last 11y
BIO +129.9%TDOC -64.8%BIO compounded faster
Log scale — wide-divergence pair
101001k10kStart $10020172019202120232025$230$35
BIO TDOC

BIO vs TDOC: by the numbers

  • BIO is the larger company ($9.34B vs $1.29B market cap).
  • BIO is profitable (8.59% net margin) while TDOC runs a net loss (-7.13%).
  • TDOC grew revenue faster over the past five years (8.85% vs 0.29% CAGR).

Metrics side by side

Valuation

MetricBIOTDOC
P/E ratio41.51N/A
Forward P/E37.87N/A
P/S ratio3.550.48
P/B ratio1.280.92
EV / EBITDA25.8914.32
FCF yield3.85%18.69%

Profitability

MetricBIOTDOC
Gross margin51.90%73.53%
Operating margin9.08%-6.98%
Net margin8.59%-7.13%
ROE3.10%-13.54%
ROIC2.04%-8.26%

Growth (annualized)

MetricBIOTDOC
Revenue CAGR (5Y)0.29%8.85%
EPS CAGR (5Y)-26.27%N/A
FCF CAGR (5Y)-9.65%25.56%
Total return CAGR (5Y)-14.60%-46.28%

Frequently asked

Which has grown faster, BIO or TDOC?
Over the past five years, TDOC grew revenue faster — BIO at a 0.29% CAGR versus TDOC at 8.85%.
Is BIO or TDOC more profitable?
BIO runs the higher net margin — BIO at 8.59% versus TDOC at -7.13%.
How have BIO and TDOC total returns compared?
Over the past 10 years, BIO delivered 8.19% and TDOC delivered -8.72% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 6, 2026.